Integration of relative elevation of NT-proBNP plasma level and relative reduction of the 2D LV-GLS may be helpful in the early detection (as early as 6 weeks after the first chemotherapy dose) of chemotherapy-induced cardiotoxicity in asymptomatic breast cancer female patients. The gene discussed is NPPB; the disease is breast carcinoma.